Patent Assignment
Reel/Frame 055534/0701
Assignment of Assignor's Interest
Recorded: 2021-03-09
Pages: 19
Assignors
DRAPPA, JORN
Executed: 2021-02-18
GRANT, ETHAN
Executed: 2021-01-29
ALBULESCU, MARIUS
Executed: 2021-02-04
STREICHER, KATIE
Executed: 2021-02-02
LI, JING
Executed: 2021-02-24
Assignee
VIELA BIO, INC.
ONE MEDIMMUNE WAY, FIRST FLOOR, AREA TWO, GAITHERSBURG, MARYLAND, 20878
Covered Properties
(4)
CD40L Antagonist and Uses Thereof
Application:
62/736,851 →
PCT:
PCT/US2019/052997 ↗
CD40L Antagonist and Uses Thereof
Application:
62/747,552 →
CD40L Antagonist and Uses Thereof
Application:
62/758,060 →
CD40L Antagonist and Uses Thereof
Application:
62/853,575 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 9, 2021
From: REES, WILLIAM; ILLEI, GABOR; WANG, LIANGWEI
To: VIELA BIO, INC.
Reel/Frame 055534/0988 →
Security Agreement
Mar 15, 2021
From: HORIZON ORPHAN LLC; HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
To: CITIBANK, N.A.
Reel/Frame 055659/0430 →
Release of Security Interest
Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS U.S. HOLDING LLC (FKA HORIZON ORPHAN LLC); HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
Reel/Frame 065154/0064 →